IL196600A0 - Transcription infidelity, detection and uses thereof - Google Patents

Transcription infidelity, detection and uses thereof

Info

Publication number
IL196600A0
IL196600A0 IL196600A IL19660009A IL196600A0 IL 196600 A0 IL196600 A0 IL 196600A0 IL 196600 A IL196600 A IL 196600A IL 19660009 A IL19660009 A IL 19660009A IL 196600 A0 IL196600 A0 IL 196600A0
Authority
IL
Israel
Prior art keywords
infidelity
detection
transcription infidelity
design
disease
Prior art date
Application number
IL196600A
Other languages
English (en)
Original Assignee
Transmedi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transmedi Sa filed Critical Transmedi Sa
Publication of IL196600A0 publication Critical patent/IL196600A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Glass Compositions (AREA)
  • Pit Excavations, Shoring, Fill Or Stabilisation Of Slopes (AREA)
  • Peptides Or Proteins (AREA)
IL196600A 2006-07-20 2009-01-19 Transcription infidelity, detection and uses thereof IL196600A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06291176A EP1887088A1 (en) 2006-07-20 2006-07-20 Transcription infidelity, detection and uses thereof
PCT/EP2007/057541 WO2008009751A2 (en) 2006-07-20 2007-07-20 Transcription infidelity, detection and uses thereof

Publications (1)

Publication Number Publication Date
IL196600A0 true IL196600A0 (en) 2009-11-18

Family

ID=37496681

Family Applications (1)

Application Number Title Priority Date Filing Date
IL196600A IL196600A0 (en) 2006-07-20 2009-01-19 Transcription infidelity, detection and uses thereof

Country Status (18)

Country Link
US (1) US8288091B2 (https=)
EP (3) EP1887088A1 (https=)
JP (1) JP5298013B2 (https=)
KR (1) KR101502179B1 (https=)
AT (1) ATE524565T1 (https=)
AU (1) AU2007275068B2 (https=)
BR (1) BRPI0714563B8 (https=)
CA (1) CA2658305C (https=)
CY (2) CY1112125T1 (https=)
DK (2) DK2468885T3 (https=)
ES (2) ES2553435T3 (https=)
HU (1) HUE028135T2 (https=)
IL (1) IL196600A0 (https=)
PL (2) PL2046986T3 (https=)
PT (2) PT2468885E (https=)
SI (2) SI2468885T1 (https=)
TR (1) TR201112295Y (https=)
WO (1) WO2008009751A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2071334A1 (en) 2007-12-14 2009-06-17 Transmedi SA Compositions and methods of detecting TIABS
EP2080812A1 (en) 2008-01-18 2009-07-22 Transmedi SA Compositions and methods of detecting post-stop peptides
EP2995688A1 (en) 2014-09-12 2016-03-16 Genclis Methods of prognosing and treating triple negative breast cancer
US20170168055A1 (en) * 2015-12-11 2017-06-15 Expression Pathology, Inc. SRM/MRM Assays
CN109564204B (zh) * 2016-03-18 2021-12-10 真克里斯公司 变态反应的分子起源
WO2018187216A1 (en) * 2017-04-03 2018-10-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Expression cassettes and methods for detecting transcription errors
EP3700856A4 (en) 2017-10-26 2021-12-15 Ultima Genomics, Inc. METHODS AND SYSTEMS FOR SEQUENCE CALL
WO2020185790A1 (en) 2019-03-10 2020-09-17 Ultima Genomics, Inc. Methods and systems for sequence calling
BR112022002365A2 (pt) 2019-08-09 2022-04-26 Nutcracker Therapeutics Inc Métodos e aparelhos para fabricar e para remover material de uma composição terapêutica
KR102334576B1 (ko) * 2019-08-12 2021-12-07 한국생명공학연구원 융합 단백질 및 이를 포함하는 바이오 이미징용 조성물
EP4211268A4 (en) * 2020-09-10 2024-09-18 Ultima Genomics, Inc. SEQUENCE AND VARIANT CALLING METHODS AND SYSTEMS
WO2022108309A1 (ko) * 2020-11-18 2022-05-27 한양대학교 에리카산학협력단 인산화된 비멘틴의 과도한 생성을 차단하여 암을 예방 또는 치료하는 방법
EP4162948A1 (en) 2021-10-05 2023-04-12 Genclis Transcription infidelity derived chimeric immunogens and uses thereof
WO2023104904A2 (en) 2021-12-08 2023-06-15 Genclis The sars-cov-2 and variants use two independent cell receptors to replicate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4979330A (en) 1989-10-10 1990-12-25 Rorant Julius W Suction insect trap device
US6120992A (en) 1993-11-04 2000-09-19 Valigene Corporation Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, and allele identification in a diseased human
WO2001040804A2 (en) * 1999-12-03 2001-06-07 Koninklijke Nederlandse Akademie Van Wetenschappen Clearance of aberrant protein in correlation with disease
WO2002077286A1 (en) 2001-02-21 2002-10-03 Gene Check, Inc. Mutation detection using muts and reca
US20060110762A1 (en) * 2004-11-10 2006-05-25 Sanjay Kapil Porcine reproductive and respiratory syndrome virus receptor components and uses thereof

Also Published As

Publication number Publication date
EP2468885A2 (en) 2012-06-27
US8288091B2 (en) 2012-10-16
ATE524565T1 (de) 2011-09-15
PT2046986E (pt) 2011-12-29
PT2468885E (pt) 2015-11-26
PL2046986T3 (pl) 2012-02-29
AU2007275068A1 (en) 2008-01-24
PL2468885T3 (pl) 2016-04-29
HK1128937A1 (en) 2009-11-13
CY1112125T1 (el) 2015-11-04
CA2658305A1 (en) 2008-01-24
JP2009544284A (ja) 2009-12-17
DK2046986T3 (da) 2012-01-02
BRPI0714563B8 (pt) 2021-05-25
WO2008009751A2 (en) 2008-01-24
ES2373428T3 (es) 2012-02-03
ES2553435T3 (es) 2015-12-09
US20090317386A1 (en) 2009-12-24
AU2007275068B2 (en) 2013-06-06
EP2046986B1 (en) 2011-09-14
CY1116939T1 (el) 2017-04-05
BRPI0714563B1 (pt) 2019-07-02
SI2046986T1 (sl) 2012-05-31
CA2658305C (en) 2017-07-18
EP2046986A2 (en) 2009-04-15
WO2008009751A3 (en) 2008-07-31
KR101502179B1 (ko) 2015-03-12
SI2468885T1 (sl) 2016-02-29
KR20090052861A (ko) 2009-05-26
EP2468885A3 (en) 2012-08-29
TR201112295Y (tr) 2018-08-27
BRPI0714563A2 (pt) 2015-04-14
EP2468885B1 (en) 2015-08-19
HUE028135T2 (en) 2016-12-28
JP5298013B2 (ja) 2013-09-25
EP1887088A1 (en) 2008-02-13
DK2468885T3 (da) 2016-02-29

Similar Documents

Publication Publication Date Title
IL196600A0 (en) Transcription infidelity, detection and uses thereof
WO2010082944A3 (en) Systems and methods for imaging changes in tissue
WO2007098070A3 (en) Non-invasive methods for evaluating retinal affecting neurodegenerative diseases
WO2008088849A3 (en) Inflammation treatment, detection and monitoring via trem-1
WO2009085234A3 (en) Use of micro-rna as a biomarker of immunomodulatory drug activity
DK1991697T3 (da) DNA-konformation (LOOP-strukturer) ved normal og anormal genekspression
MX343327B (es) Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa.
GB2463401B (en) Characterizing prostate disorders by analysis of microvesicles
HRP20130618T1 (en) Methods of using mirna for detection of in vivo cell death
WO2009102895A3 (en) Method to predict response to pharmacological chaperone treatment of diseases
WO2010054386A3 (en) Methods, compositions, and devices utilizing microrna to determine physiological conditions
WO2011057003A3 (en) Methods of using small rna from bodily fluids for diagnosis and monitoring of neurodegenerative diseases
WO2006073682A3 (en) Diagnostic test
WO2007110623A3 (en) Screening method
EP2857522A3 (en) Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy
WO2009001545A1 (ja) 移植片対宿主疾患の検査および治療方法
NO20074610L (no) Fremgangsmate for a bestemme mottakeligheten til CHK1 inhibitorer
WO2011052906A3 (en) Use of eif3m for the diagnosis and treatment of cancer
WO2008060400A3 (en) Sirtuin polymorphisms and methods of use thereof
WO2008005771A3 (en) Methods for identifying patients with increased risk of an adverse cardiovascular event
WO2005089310A3 (en) Breath test for oral malodor
WO2006074450A3 (en) Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
WO2008012692A3 (en) Assay for efficacy of histone deacetylase inhibitors
BR112014007947A2 (pt) método para monitoramento, diagnóstico e/ou prognóstico de distúrbios relacionados à hipoxia usando nfat5
WO2009143512A3 (en) Compositions and methods relating to detection of soluble e-cadherin in neurodegenerative disease

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed